BC Platforms Provides Complete Data Management Solution for Debiopharm's Oncology Development Portfolio
Summary
In doing so, the company expects to provide greater insights into Debiopharms development pipeline in order to support specific therapeutic strategies and add value to potential partnering discussions. René van den Bersselaar, CIO at Debiopharm International commented on the partnership, "We are very confident in BC Platforms ability to manage and integrate vast amounts of clinical and genomic data in a manner that will provide valuable insights to support our development programs, particular in the area of oncology. Debiopharm has been extremely visionary in its approach to digital health in research and data management and we look forward to supporting them in building additional value for their customers and patients." Founded in 1997 from an MIT Whitehead project spinoff, the Company has a strong scientific heritage underpinned by over 20 years of working in close collaboration with a network of leading researchers, developers, manufacturers and vendors. BC Platforms has global operations with its headquarters in Zurich, Switzerland, research and development in Espoo, Finland, and sales and marketing in London, Boston, and Vancouver.
Classifications
AskAI Classifications
LabelsLinked Companies
